Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

[1]  Raúl San José Estépar,et al.  Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality. , 2020, European journal of radiology.

[2]  Raúl San José Estépar,et al.  Classification of Interstitial Lung Abnormality Patterns with an Ensemble of Deep Convolutional Neural Networks , 2020, Scientific Reports.

[3]  L. Wain,et al.  Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[4]  A. Nicholson,et al.  Pleuroparenchymal Fibroelastosis: A Review of Clinical, Radiological and Pathological Characteristics. , 2019, Annals of the American Thoracic Society.

[5]  S. Walsh,et al.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. , 2019, The New England journal of medicine.

[6]  Ivana V. Yang,et al.  MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis , 2019, Thorax.

[7]  Eui Jin Hwang,et al.  Significant Abnormalities Other than Lung Cancer in Korean Lung Cancer CT Screening , 2019, Journal of the Korean Society of Radiology.

[8]  M. Okada,et al.  Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer. , 2019, Respiratory investigation.

[9]  I. Sohn,et al.  Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer , 2019, Respiratory Research.

[10]  Y. Kawabata,et al.  Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal. , 2019, Respiratory investigation.

[11]  T. Baba,et al.  Computer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival. , 2019, Radiology.

[12]  G. Raghu,et al.  Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. , 2019, The New England journal of medicine.

[13]  G. Washko,et al.  Imaging Patterns are Associated with Interstitial Lung Abnormality Progression and Mortality. , 2019, American journal of respiratory and critical care medicine.

[14]  H. Hatabu,et al.  Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions. , 2019, Human pathology.

[15]  D. Lynch,et al.  Interstitial Lung Abnormality: Recognition and Perspectives. , 2019, Radiology.

[16]  H. Hatabu,et al.  Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome , 2019, European journal of radiology open.

[17]  Hyae-Young Kim,et al.  Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program , 2019, Cancer research and treatment : official journal of Korean Cancer Association.

[18]  Eric A Hoffman,et al.  Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis , 2019, American journal of respiratory and critical care medicine.

[19]  J. Schwartz,et al.  Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study , 2019, Thorax.

[20]  J. Myers,et al.  A Review of Smoking-Related Interstitial Fibrosis, Respiratory Bronchiolitis, and Desquamative Interstitial Pneumonia: Overlapping Histology and Confusing Terminology. , 2018, Archives of pathology & laboratory medicine.

[21]  Takeshi Johkoh,et al.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.

[22]  Jonathan H. Chung,et al.  Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography , 2018, Annals of the American Thoracic Society.

[23]  Ming Chen,et al.  Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy , 2018, Radiation oncology.

[24]  W. Boyd,et al.  Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement. , 2018, Respiratory medicine.

[25]  A. Dirksen,et al.  Interstitial lung abnormalities are associated with increased mortality in smokers. , 2018, Respiratory medicine.

[26]  M. Suarez‐Almazor,et al.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  D. Lynch,et al.  Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. , 2017, The Lancet. Respiratory medicine.

[28]  G. Washko,et al.  Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections , 2017, American journal of respiratory and critical care medicine.

[29]  Joon Beom Seo,et al.  Comparison of Shallow and Deep Learning Methods on Classifying the Regional Pattern of Diffuse Lung Disease , 2018, Journal of Digital Imaging.

[30]  Sang Min Lee,et al.  Prediction of survival by texture-based automated quantitative assessment of regional disease patterns on CT in idiopathic pulmonary fibrosis , 2018, European Radiology.

[31]  E. Hoffman,et al.  High‐Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community‐Dwelling Adults , 2017, American journal of respiratory and critical care medicine.

[32]  E. Hoffman,et al.  Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air–lung study , 2017, European Respiratory Journal.

[33]  D. Lynch,et al.  Toward Early Identification of Clinically Relevant Interstitial Lung Disease. , 2017, American journal of respiratory and critical care medicine.

[34]  M. Suarez‐Almazor,et al.  Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group , 2017, Journal of Immunotherapy for Cancer.

[35]  E. Hoffman,et al.  Serum Matrix Metalloproteinase‐7, Respiratory Symptoms, and Mortality in Community‐Dwelling Adults. MESA (Multi‐Ethnic Study of Atherosclerosis) , 2017, American journal of respiratory and critical care medicine.

[36]  Carlos Flores,et al.  Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study , 2017, The Lancet. Respiratory medicine.

[37]  E. Hoffman,et al.  Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi‐Ethnic Study of Atherosclerosis) Air and Lung Studies , 2017, American journal of respiratory and critical care medicine.

[38]  Raúl San José Estépar,et al.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers , 2017, Chest.

[39]  Raúl San José Estépar,et al.  The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes , 2017, European Respiratory Journal.

[40]  Raúl San José Estépar,et al.  The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers. , 2017, Academic radiology.

[41]  Edwin J R van Beek,et al.  Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up. , 2017, Radiology.

[42]  D. Lynch,et al.  Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial , 2017, European Respiratory Journal.

[43]  Joon Beom Seo,et al.  An Ensemble Method for Classifying Regional Disease Patterns of Diffuse Interstitial Lung Disease Using HRCT Images from Different Vendors , 2017, Journal of Digital Imaging.

[44]  H. Hatabu,et al.  Interstitial Lung Abnormalities Are Associated with Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[45]  Raúl San José Estépar,et al.  Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. , 2016, American journal of respiratory and critical care medicine.

[46]  Sang Min Lee,et al.  Texture-Based Automated Quantitative Assessment of Regional Patterns on Initial CT in Patients With Idiopathic Pulmonary Fibrosis: Relationship to Decline in Forced Vital Capacity. , 2016, AJR. American journal of roentgenology.

[47]  J. Austin,et al.  High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study , 2016, European Respiratory Journal.

[48]  N. Nitta,et al.  Smoking-related interstitial fibrosis combined with pulmonary emphysema: computed tomography-pathologic correlative study using lobectomy specimens , 2016, International journal of chronic obstructive pulmonary disease.

[49]  Brent S. Pedersen,et al.  Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia , 2016, BMC Genetics.

[50]  Raúl San José Estépar,et al.  Association Between Interstitial Lung Abnormalities and All-Cause Mortality. , 2016, JAMA.

[51]  L. Ebner,et al.  Multi-source Transfer Learning with Convolutional Neural Networks for Lung Pattern Analysis , 2016, IEEE journal of biomedical and health informatics.

[52]  Raúl San José Estépar,et al.  A comparison of visual and quantitative methods to identify interstitial lung abnormalities , 2015, BMC Pulmonary Medicine.

[53]  K. Kurashima,et al.  Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. , 2015, European journal of radiology.

[54]  H. Hatabu,et al.  Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival. , 2015, European journal of radiology.

[55]  J. W. Lee,et al.  Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. , 2015, American journal of respiratory and critical care medicine.

[56]  A. Azuma,et al.  A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .

[57]  D. Lynch,et al.  Smoking-related idiopathic interstitial pneumonia , 2014, European Respiratory Journal.

[58]  R. Sussman,et al.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[59]  H. Collard,et al.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[60]  Y. Korogi,et al.  Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. , 2013, Lung cancer.

[61]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[62]  Richard A. Robb,et al.  Quantitative Computed Tomography Imaging of Interstitial Lung Diseases , 2013, Journal of thoracic imaging.

[63]  D. Lynch,et al.  Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. , 2013, Radiology.

[64]  Raúl San José Estépar,et al.  MUC5B promoter polymorphism and interstitial lung abnormalities. , 2013, The New England journal of medicine.

[65]  Naftali Kaminski,et al.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.

[66]  Brent S. Pedersen,et al.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.

[67]  Sarah J. Johnson,et al.  Standards and datasets for reporting cancers , 2013 .

[68]  I. Rosas,et al.  Subclinical interstitial lung disease: why you should care. , 2012, American journal of respiratory and critical care medicine.

[69]  T. Kanauchi,et al.  Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically , 2012, Respirology.

[70]  Sang Min Lee,et al.  Quantitative assessment of change in regional disease patterns on serial HRCT of fibrotic interstitial pneumonia with texture-based automated quantification system , 2012, European Radiology.

[71]  G. Washko,et al.  Interstitial lung abnormalities and reduced exercise capacity. , 2012, American journal of respiratory and critical care medicine.

[72]  Antoine Geissbühler,et al.  Building a reference multimedia database for interstitial lung diseases , 2012, Comput. Medical Imaging Graph..

[73]  A. Diaz de Leon,et al.  Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations. , 2011, Chest.

[74]  Ivana V. Yang,et al.  A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.

[75]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[76]  Katherine P Andriole,et al.  Lung volumes and emphysema in smokers with interstitial lung abnormalities. , 2011, The New England journal of medicine.

[77]  C. la Vecchia,et al.  Interstitial lung diseases in a lung cancer screening trial , 2011, European Respiratory Journal.

[78]  S. Sone,et al.  The radiological patterns of interstitial change at an early phase: over a 4-year follow-up. , 2010, Respiratory medicine.

[79]  S. Mukhopadhyay,et al.  Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. , 2010, Human pathology.

[80]  Raúl San José Estépar,et al.  Identification of early interstitial lung disease in smokers from the COPDGene Study. , 2010, Academic radiology.

[81]  W. Travis,et al.  Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. , 2009, Archives of pathology & laboratory medicine.

[82]  Edwin J R van Beek,et al.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. , 2009, American journal of respiratory and critical care medicine.

[83]  Joon Beom Seo,et al.  Feasibility of Automated Quantification of Regional Disease Patterns Depicted on High-Resolution Computed Tomography in Patients with Various Diffuse Lung Diseases , 2009, Korean journal of radiology.

[84]  D. Hansell,et al.  Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old. , 2009, Radiology.

[85]  K. Kurashima,et al.  Smoking‐related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course , 2008, Histopathology.

[86]  G. Raghu,et al.  Telomere shortening in familial and sporadic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.

[87]  Y. Sugita,et al.  Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? , 2008, Respirology.

[88]  W. Travis,et al.  Early interstitial lung disease in familial pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.

[89]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[90]  S. Yousem.  Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal , 2006, Modern Pathology.

[91]  A. Nicholson,et al.  Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking , 2004, Histopathology.

[92]  T. Hartman,et al.  The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. , 2003, Chest.

[93]  M. Schwarz,et al.  Interstitial Lung Disease , 2003 .

[94]  J. Remy,et al.  Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. , 2002, Radiology.

[95]  T. Hartman,et al.  Smoking-related interstitial lung diseases: a concise review. , 2001, The European respiratory journal.

[96]  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). , 2000, American journal of respiratory and critical care medicine.

[97]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[98]  E. Hoffman,et al.  Interstitial lung disease: A quantitative study using the adaptive multiple feature method. , 1999, American journal of respiratory and critical care medicine.

[99]  J. Remy,et al.  Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. , 1993, Radiology.

[100]  J. Remy,et al.  Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. , 1993, Radiology.

[101]  J. Remy,et al.  Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. , 1993, Radiology.

[102]  D. Aberle,et al.  Asbestos-related pleural and parenchymal fibrosis: detection with high-resolution CT. , 1988, Radiology.